Rosales, Thinan L.

HRN: 27-96-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFTRIAXONE 1G (VIAL)
10/18/2025
10/25/2025
IV
660MG
OD
PCAP-C
Waiting Final Action 
10/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/19/2025
10/26/2025
IV
100mg
Q24
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: